Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction

Journal of Physiology

Volumn 591, Issue 17, 2013, Pages 4335-4349

  Yamada, Satsuki ^a   Nelson, Timothy J ^a   Kane, Garvan C ^a   Martinez Fernandez, Almudena ^a   Crespo Diaz, Ruben J ^a   Ikeda, Yasuhiro ^a   Perez Terzic, Carmen ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; KRUPPEL LIKE FACTOR; POU5F1 PROTEIN, MOUSE; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC DYSSYNCHRONY; CARDIAC RESYNCHRONIZATION THERAPY; CELL FATE; CELL GROWTH; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART STIMULATION; HEART VENTRICLE CONDUCTION; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE WALL MOTION; HISTOLOGY; HUMAN; MALE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POST HEART INFARCTION; PRIORITY JOURNAL; SCAR FORMATION; SPECKLE TRACKING ECHOCARDIOGRAPHY; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CYTOLOGY; ECHOGRAPHY; FIBROBLAST; GENETICS; HEART CONTRACTION; HEART VENTRICLE FUNCTION; HEART VENTRICLE SEPTUM; METABOLISM; MYOCARDIAL INFARCTION; NUCLEAR REPROGRAMMING; TRANSPLANTATION;

ANIMALS; CARDIAC RESYNCHRONIZATION THERAPY; CELLULAR REPROGRAMMING; FIBROBLASTS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS; STEM CELL TRANSPLANTATION; VENTRICULAR FUNCTION; VENTRICULAR SEPTUM;

EID: 84883281972     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.252288     Document Type: Article

References (50)

1. Abraham T, Kass D, Tonti G, Tomassoni GF, Abraham WT, Bax JJ & Marwick TH (2009). Imaging cardiac resynchronization therapy. JACC Cardiovasc Imaging 2, 486-497.
2. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF & Gorcsan J 3rd (2011). Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 32, 93-103.
3. Anderson LJ, Miyazaki C, Sutherland GR & Oh JK (2008). Patient selection and echocardiographic assessment of dyssynchrony in cardiac resynchronization therapy. Circulation 117, 2009-2023.
4. Auricchio A & Prinzen FW (2008). Update on the pathophysiological basics of cardiac resynchronization therapy. Europace 10, 797-800.
5. Auricchio A & Prinzen FW (2011). Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 75, 521-527.
6. Bartunek J, Vanderheyden M, Hill J & Terzic A (2010). Cells as biologics for cardiac repair in ischaemic heart failure. Heart 96, 792-800.
7. Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, Trujillo A, Lin FC & Liao R (2011). Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res 108, 908-916.
8. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J & Terzic A (2010). Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56, 721-734.
9. Bers DM & Harris SP (2011). Translational medicine: to the rescue of the failing heart. Nature 473, 36-39.
10. Bijnens BH, Cikes M, Claus P & Sutherland GR (2009). Velocity and deformation imaging for the assessment of myocardial dysfunction. Eur J Echocardiogr 10, 216-226.
11. Bonios M, Chang CY, Pinheiro A, Dimaano VL, Higuchi T, Melexopoulou C, Bengel F, Terrovitis J, Abraham TP & Abraham MR (2011). Cardiac resynchronization by cardiosphere-derived stem cell transplantation in an experimental model of myocardial infarction. J Am Soc Echocardiogr 24, 808-814.
12. Carasso S, Rakowski H, Witte KK, Smith P, Carasso D, Garceau P, Sasson Z & Parker JD (2009). Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. J Am Soc Echocardiogr 22, 242-250.
13. Chang SA, Kim HK, Lee HY, Choi SY, Koo BK, Kim YJ, Sohn DW, Oh BH, Park YB, Choi YS, Kang HJ & Kim HS (2008). Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction. Heart 94, 995-1001.
14. Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF, Breithard O, Brignole M, Cleland J, Delurgio DB, Dickstein K, Exner DV, Gold M, Grimm RA, Hayes DL, Israel C, Leclercq C, Linde C, Lindenfeld J, Merkely B, Mont L, Murgatroyd F, Prinzen F, Saba SF, Shinbane JS, Singh J, Tang AS, Vardas PE, Wilkoff BL & Zamorano JL (2012). EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm 9, 1524-1576.
15. De Boeck BW, Teske AJ, Meine M, Leenders GE, Cramer MJ, Prinzen FW & Doevendans PA (2009). Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal response. Eur J Heart Fail 11, 863-871.
16. Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ & Terzic A (2013). Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J Cardiovasc Transl Res 6, 10-21.
17. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C & Terzic A (2011). Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 14, 264-271.
18. Gorcsan J 3rd & Prinzen FW (2012). Understanding the cardiac substrate and the underlying physiology: Implications for individualized treatment algorithm. Heart Rhythm 9, S18-26.
19. Gorcsan J 3rd & Tanaka H (2011). Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58, 1401-1413.
20. Herbots L, D'hooge J, Eroglu E, Thijs D, Ganame J, Claus P, Dubois C, Theunissen K, Bogaert J, Dens J, Kalantzi M, Dymarkowski S, Bijnens B, Belmans A, Boogaerts M, Sutherland G, Van de Werf F, Rademakers F & Janssens S (2009). Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J 30, 662-670.
21. Janssens S (2010). Stem cells in the treatment of heart disease. Annu Rev Med 61, 287-300.
22. Kass DA (2009). Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 6, 1660-1665.
23. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP & Dutka DP (2012). Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 59, 1509-1518.
24. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y & Terzic A (2009). iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 105, 648-656.
25. Mauritz C, Martens A, Rojas SV, Schnick T, Rathert C, Schecker N, Menke S, Glage S, Zweigerdt R, Haverich A, Martin U & Kutschka I (2011). Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 32, 2634-2641.
26. Mele D, Agricola E, Galderisi M, Rigo F, Citro R, Dal Monte A, Della Valentina P, Calabrese A & Ferrari R; Study Group of Echocardiography, Italian Society of Cardiology (2009). Echocardiographic myocardial scar burden predicts response to cardiac resynchronization therapy in ischemic heart failure. J Am Soc Echocardiogr 22, 702-708.
27. Menasche P (2011). Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 50, 258-265.
28. Mollema SA, Liem SS, Suffoletto MS, Bleeker GB, van der Hoeven BL, van de Veire NR, Boersma E, Holman ER, van der Wall EE, Schalij MJ & Gorcsan J 3rd (2007). Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling. J Am Coll Cardiol 50, 1532-1540.
29. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A & Laugwitz KL (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363, 1397-1409.
30. Nelson TJ, Martinez-Fernandez A & Terzic A (2010). Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol 7, 700-710.
31. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y & Terzic A (2009). Repair of acute myocardial infarction with iPS induced by human stemness factors. Circulation 120, 408-416.
32. Nelson TJ & Terzic A (2011). Induced pluripotent stem cells: an emerging theranostics platform. Clin Pharmacol Ther 89, 648-650.
33. Nucifora G, Bertini M, Marsan NA, Delgado V, Scholte AJ, Ng AC, van Werkhoven JM, Siebelink HM, Holman ER, Schalij MJ, van der Wall EE & Bax JJ (2010). Impact of left ventricular dyssynchrony early on left ventricular function after first acute myocardial infarction. Am J Cardiol 105, 306-311.
34. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H & Murry CE (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21, 1345-1357.
35. Penn MS, Dong F, Klein S & Mayorga ME (2011). Stem cells for myocardial regeneration. Clin Pharmacol Ther 90, 499-501.
36. Petersen JW, Forder JR, Thomas JD, Moyé LA, Lawson M, Loghin C, Traverse JH, Baraniuk S, Silva G & Pepine CJ; CCTRN (Cardiovascular Cell Therapy Research Network) (2011). Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials. JACC Cardiovasc Imaging 4, 671-679.
37. Pokushalov E, Romanov A, Corbucci G, Prohorova D, Chernyavsky A, Larionov P, Terekhov I, Artyomenko S, Kliver E, Shirokova N, Karaskov A & Dib N (2011). Cardiac resynchronization therapy and bone marrow cell transplantation in patients with ischemic heart failure and electromechanical dyssynchrony: a randomized pilot study. J Cardiovasc Transl Res 4, 767-778.
38. Popović ZB, Benejam C, Bian J, Mal N, Drinko J, Lee K, Forudi F, Reeg R, Greenberg NL, Thomas JD & Penn MS (2007). Speckle-tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 292, H2809-H2816.
39. Riedlbauchová L, Brunken R, Jaber WA, Popová L, Patel D, Lánská V, Civello K, Cummings J, Burkhardt JD, Saliba W, Martin D, Schweikert R, Wilkoff BL, Grimm R & Natale A (2009). The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 20, 50-57.
40. Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Hsiao JF, Maalouf JF, Ammash NM, McCully RB, Miller FA, Pellikka PA, Oh JK & Kane GC (2011). Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 139, 1299-1309.
41. Shin SH, Hung CL, Uno H, Hassanein AH, Verma A, Bourgoun M, Køber L, Ghali JK, Velazquez EJ, Califf RM, Pfeffer MA & Solomon SD; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators (2010). Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both. Circulation 121, 1096-1103.
42. Singla DK, Long X, Glass C, Singla RD & Yan B (2011). Induced pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Mol Pharm 8, 1573-1581.
43. Smith NP, McCulloch AD & Paterson DJ (2012). What can modelling provide to cardiac physiology J Physiol 590, 4401-4402.
44. van Ramshorst J, Atsma DE, Beeres SL, Mollema SA, Ajmone Marsan N, Holman ER, van der Wall EE, Schalij MJ & Bax JJ (2009). Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart 95, 119-124.
45. Wollert KC & Drexler H (2010). Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 7, 204-215.
46. Yamanaka S (2012). Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10, 678-684.
47. + channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J Physiol 577, 1053-1065.
48. Yamada S, Nelson TJ, Behfar A, Crespo-Diaz RJ, Fraidenraich D & Terzic A (2009). Transplant into pre-implantation embryo yields myocardial infarction-resistant adult phenotype. Stem Cells 27, 1697-1705.
49. Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK, Miki T, Seino S, Behfar A & Terzic A (2008). Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 26, 2644-2653.
50. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA & Kamp TJ (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104, e30-41.